The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells

被引：0
|
作者：
Brigitte L Thériault
Paulina Cybulska
Patricia A Shaw
Brenda L Gallie
Marcus Q Bernardini
机构：
[1] University Health Network,Campbell Family Cancer Research Institute, Ontario Cancer Institute
[2] University of Toronto,Department of Obstetrics and Gynecology
[3] University Health Network,Division of Gynecological Oncology
[4] University Health Network,Department of Pathology
[5] University Health Network Tissue Bank,Princess Margaret Hospital
[6] Toronto Western Hospital Research Institute,Division of Visual Science
[7] University of Toronto,Departments of Medical Biophysics, Molecular Genetics, and Ophthalmology
[8] Princess Margaret Cancer Centre,undefined
来源：
Journal of Ovarian Research | / 7卷
关键词：
KIF14; Ovarian tumor tissue; Primary culture; shRNA; Proliferation; Colony formation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells
    Theriault, Brigitte L.
    Cybulska, Paulina
    Shaw, Patricia A.
    Gallie, Brenda L.
    Bernardini, Marcus Q.
    JOURNAL OF OVARIAN RESEARCH, 2014, 7
  • [2] Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids
    Graham, Olivia
    Rodriguez, Jeimmy
    van Biljon, Lillian
    Fashemi, Bisiayo
    Graham, Emily
    Fuh, Katherine
    Khabele, Dlneo
    Mullen, Mary
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2023, (191):
  • [3] Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts
    Topp, Monique D.
    Hartley, Lynne
    Cook, Michele
    Heong, Valerie
    Boehm, Emma
    McShane, Lauren
    Pyman, Jan
    McNally, Orla
    Ananda, Sumitra
    Harrell, Marisol
    Etemadmoghadam, Dariush
    Galletta, Laura
    Alsop, Kathryn
    Mitchell, Gillian
    Fox, Stephen B.
    Kerr, Jeffrey B.
    Hutt, Karla J.
    Kaufmann, Scott H.
    Swisher, Elizabeth M.
    Bowtell, David D.
    Wakefield, Matthew J.
    Scott, Clare L.
    MOLECULAR ONCOLOGY, 2014, 8 (03) : 656 - 668
  • [4] EXPLORATION OF RESISTANCE OF PARP INHIBITOR THERAPY IN HIGH-GRADE SEROUS OVARIAN CANCER PATIENT-DERIVED XENOGRAFTS.
    Ye, L.
    Topp, M.
    Boehm, E.
    Hadley, A.
    Cook, M.
    Heong, V.
    Pyman, J.
    McNally, O.
    Ananda, S.
    Harrell, M.
    Alsop, K.
    Bowtell, D. D.
    Johnson, N.
    Kaufmann, S. H.
    Swisher, E. M.
    Wakefield, M.
    Scott, C. L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 407 - 408
  • [5] Establishment and analysis of patient-derived high-grade serous ovarian cancer organoids for disease modeling and drug testing
    Kallunki, Tuula
    Lauridsen, Anna R.
    Skorda, Aikaterini
    Lahtinen, Alexandra
    Bay, Marie L.
    Rasmussen, Benita
    Huhtinen, Kaisa
    Muranen, Taru
    Oikkonen, Jaana
    Hynninen, Johanna
    Hautaniemi, Sampsa
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Patient-derived immunocompetent cultures reveal personalized immunotherapies and new treatment options for therapy resistant patients with high-grade serous ovarian cancer
    Farkkila, Anniina
    Nagaraj, Ashwini S.
    Pietila, Elina A.
    Salko, Matilda
    Erkan, Erdogan P.
    Niemiec, Iga
    Sirsikar, Aditi
    Bao, Jie
    Marchi, Giovanni
    Nowlan, Kirsten
    Hautaniemi, Sampsa
    Vaharautio, Anna
    Tang, Jing
    Haltia, Ulla-Maija
    Kekalainen, Eliisa
    Virtanen, Anni
    Salo, Tuula
    CANCER RESEARCH, 2024, 84 (05)
  • [7] USING PATIENT-DERIVED XENOGRAFTS TO DEFINE ACTIONABLE ABERRATIONS IN HIGH-GRADE SEROUS CANCER
    Scott, Clare
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 20 - 20
  • [8] The role of Apela in high-grade serous ovarian cancer
    Daily, Laura R.
    Ganguly, Debolina
    Hayes, D. Neil
    Wang, Yinan
    Sims, Michelle M.
    Cheng, Jinjun
    ElNaggar, Adam C.
    Pfeffer, Lawrence M.
    CANCER RESEARCH, 2018, 78 (13)
  • [9] USE OF NOVEL PATIENT-DERIVED XENOGRAFTS AND MOLECULAR SUBTYPING TO IMPROVE PRECISION MEDICINE IN HIGH-GRADE SEROUS OVARIAN CANCER
    Heong, V.
    Topp, M.
    Rutkowski, R.
    Ananda, S.
    Wong, S.
    Swisher, E.
    Lindeman, G.
    Haber, M.
    Norris, M. D.
    Haluska, P.
    Wakefield, M.
    Bowtell, D.
    Scott, C. L.
    Lindeman, G.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E9 - E9
  • [10] Design of effective combination therapies for high-grade serous ovarian cancer using patient-derived xenograft models.
    Iavarone, Claudia
    Zervantonakis, Ioannis
    Chen, Hsing-Yu
    Palakurthi, Sangeetha S.
    Liu, Joyce Fu
    Matulonis, Ursula A.
    Drapkin, Ronny I.
    Mills, Gordon B.
    Leverson, Joel D.
    Sampath, Deepak
    Brugge, Joan S.
    CLINICAL CANCER RESEARCH, 2016, 22
12345